Overall rank by patents
#42,806
Across all tracked assignees
USPTO PatentsView assignee record - 6 granted patents across 10 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C03C (CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MA).
The verdict
SGD holds 6 US patents across 10 technology areas, rank #42,806 of 50,000 tracked assignees.
SGD S.a. has been granted 6 US utility patents between 2015 and 2025, placing SGD S.a. at rank #42,806 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 17.0 claims per patent with primary concentration in C03C (CHEMICAL COMPOSITION OF GLASSES, GLAZES OR VITREOUS ENAMELS; SURFACE TREATMENT OF GLASS; SURFACE TREATMENT OF FIBRES OR FILAMENTS MADE FROM GLASS, MINERALS OR SLAGS; JOINING GLASS TO GLASS OR OTHER MA). As a Foreign Corporation, SGD S.a. is one of the more focused assignees in the PatentsView dataset. By volume, SGD sits between Serene House International Enterprise Ltd. (6 patents, rank #42,802) and Shandong NHU Pharmaceutical Co., Ltd. (6 patents, rank #42,810) - the closest US assignees by grant volume. The composite Innovation Score of 41.4/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 4 grants, compared with 2 in the 2015–2019 window, a +100% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. SGD S.a.'s 17.0 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark SGD S.a. against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
SERENE HOUSE INTERNATIONAL ENTERPRISE LTD.
6 patents
SETON HEALTHCARE FAMILY
6 patents
SFI Electronics Technology Inc.
6 patents
SGCE LLC
6 patents
SHANDONG ACADEMY OF AGRICULTURAL MACHINERY SCIENCES
6 patents
SHANDONG INSTITUTE OF QUANTUM SCIENCE AND TECHNOLOGY CO., LTD.
6 patents
SHANDONG LUOXIN PHARMACEUTICAL GROUP STOCK CO., LTD.
6 patents
SHANDONG NHU PHARMACEUTICAL CO., LTD.
6 patents
SGD S.A.
6 patents
What this shows SGD holds 6 patents at rank #42,806, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #42,806 in granted patent volume.
Other assignees with the most granted patents in SGD's primary technology class.
SGD's Innovation Score vs. every tracked assignee
Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)
41 Top 33% higher than 67% of 50,000 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 2 | 33.3% |
| 2024 | 2 | 33.3% |
| 2025 | 2 | 33.3% |
Top 10 of 10 technology areas
Overall rank by patents
#42,806
Across all tracked assignees
41.4 out of 100
How to use this portfolio
SGD's 6 grants land it in the top 33% by Innovation Score, but volume alone doesn't tell you where the strength sits.
Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.